UBS Healthcare Summit 2021

AUM Biosciences presented its oncology pipeline at the UBS Healthcare Summit 2021 event. This healthcare virtual conference brings together researchers and private companies to learn about the future of healthcare technology.

AUM Biosciences, a global, clinical stage biotechnology company focused on discovering, acquiring and developing next generation targeted oncology therapeutics, was excited for Vishal Doshi, CEO, to present an overview of the company’s next-generation therapies at the Summer Private Company Showcase 2021 back on Tuesday, April 27th.

To access the presentation, please log in HERE

About AUM Biosciences

AUM Biosciences is a global clinical stage biotech company, focused on discovering and developing novel targeted oncology therapies, particularly for cancers with a clear genetic marker. The management team has an extensive track record of selecting distinctive early stage assets, successfully exiting virtual biotech models, and have contributed significantly to the development of several currently marketed oncology treatments with annual peak sales up to $3B. AUM was founded to enable a holistic strategy for drug development and improving the probability of success with a focus on synergism, sustainability and scalability.

For more information, please visit